EBS icon

Emergent Biosolutions
EBS

Overview Fund Activity

224 hedge funds and large institutions have $1.02B invested in Emergent Biosolutions in 2016 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 101 increasing their positions, 60 reducing their positions, and 27 closing their positions.

Holders
224
Holders Change
+10
Holders Change %
+4.67%
% of All Funds
5.99%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
40
Increased
101
Reduced
60
Closed
27
Calls
$1.67M
Puts
$10.6M
Net Calls
-$8.92M
Net Calls Change
-$5.31M

Top Buyers

1
Fidelity International
1
Fidelity International
Bermuda
$16.1M
2
Goldman Sachs
2
Goldman Sachs
New York
$22.2M
3
MFIMFI
3
Mesirow Financial Investment Management - Fixed Income
Illinois
$15.4M
4
Morgan Stanley
4
Morgan Stanley
New York
$18M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$102M

Top Sellers

1
Loomis, Sayles & Company
1
Loomis, Sayles & Company
Massachusetts
$7K
2
Bank of New York Mellon
2
Bank of New York Mellon
New York
$18.8M
3
Ameriprise
3
Ameriprise
Minnesota
$6.08M
4
ICRM
4
Insight Capital Research & Management
California
$0
5
PI
5
Putnam Investments
Massachusetts
$5.67M
Name Market Value Shares Shares
Change 		Shares
Change %
Susquehanna International Group
251
Susquehanna International Group
Pennsylvania
– – – –
TRCT
252
Tower Research Capital (TRC)
New York
$0 4 +4 New
KTC
253
Kistler-Tiffany Companies
Pennsylvania
$0 9 +9 New
7 8 9 10
11